Andrew Kim, M.D. is a board certified psychiatrist and an expert in the area of treating major depressive disorder who believes that delivering compassionate and data-driven care can have transformative, positive impacts on the communities we live in. Dr. Kim has worked on the forefront of psychopharmacology research and has served as a lead physician in over 100 clinical research trials over the past 6 years, playing a role in helping new FDA approved treatments for schizophrenia, major depressive disorder, bipolar disorder, and postpartum depression become available as new treatment options for patients. He believes that leveraging technology to our advantage can help advance the field of medicine as well as help deliver cost-effective and timely care. Dr. Kim believes in approaching the care of all of his patients with a holistic and evidence-based approach in order to help them on their journey to healing. Dr. Kim received his medical degree from the University of Illinois at Chicago College of Medicine, completed his psychiatry residency at the Harvard psychiatry residency training program in Boston, and completed a fellowship in consultation-liaison psychiatry at Brigham & Women's Hospital in Boston. Dr. Kim is based out of the Chicago area and remains an active public speaker for mental health advocacy and education in local communities.